ZipBio, a new Seattle biotech startup aiming to compress proteins, raises $4M
Seattle-based biotech startup ZipBio announced its official launch and revealed $4 million in a seed funding round led by NFX.
ZipBio, founded in 2023, is developing a platform that “compresses complex biological structures into smaller, more efficient de novo-designed proteins that retain full functionality, optimizing delivery and therapeutic effectiveness,” according to the company.
The company uses generative AI to transform the development of new therapeutics that address some of the most critical unmet needs in healthcare. By creating de novo genes and proteins, ZipBio distills multiple complex functions into compact highly effective therapeutic molecules.